Route of administration influences the antitumor effect of bone marrow derived dendritic cells engineered to produce Interleukin-12 in a metastatic mouse prostate cancer model

被引：0
|
作者：
Saika, T
Satoh, T
Kusaka, N
Ebara, S
Mouraviev, VB
Kumon, H
Timme, TL
Thompson, TC
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)38350-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：293 / 294
页数：2
相关论文
共 37 条
  • [1] Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model
    Saika, T
    Satoh, T
    Kusaka, N
    Ebara, S
    Mouraviev, VB
    Timme, TL
    Thompson, TC
    CANCER GENE THERAPY, 2004, 11 (05) : 317 - 324
  • [2] Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model
    Takashi Saika
    Takefumi Satoh
    Nobuyuki Kusaka
    Shin Ebara
    Vladimir B Mouraviev
    Terry L Timme
    Timothy C Thompson
    Cancer Gene Therapy, 2004, 11 : 317 - 324
  • [3] Sub-cutaneous injection of bone marrow derived dendritic cells engineered to produce interleukin-12 induces anti-tumor activities in an orthotopic mouse prostate cancer model
    Saika, T
    Kusaka, N
    Satoh, T
    Mouraviev, VB
    Yang, G
    Timme, TL
    Thompson, TC
    JOURNAL OF UROLOGY, 2002, 167 (04): : 54 - 54
  • [4] Interleukin-12 administration in retroviral infection of mice increases the potential to produce functional dendritic cells from bone marrow stem cells
    Kelleher, P
    Williams, NJ
    Knight, SC
    IMMUNOLOGY LETTERS, 1999, 65 (1-2) : 51 - 54
  • [5] Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regressions of established murine transplantable colon adenocarcinomas
    Melero, I
    Duarte, M
    Ruiz, J
    Sangro, B
    Galofré, JC
    Mazzolini, G
    Bustos, M
    Qian, C
    Prieto, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) : 217 - 217
  • [6] Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas
    Melero, I
    Duarte, M
    Ruiz, J
    Sangro, B
    Galofré, JC
    Mazzolini, G
    Bustos, M
    Qian, C
    Prieto, J
    GENE THERAPY, 1999, 6 (10) : 1779 - 1784
  • [7] Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas
    I Melero
    M Duarte
    J Ruiz
    B Sangro
    J C Galofré
    G Mazzolini
    M Bustos
    C Qian
    J Prieto
    Gene Therapy, 1999, 6 : 1779 - 1784
  • [8] Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses
    Furumoto, K
    Arii, S
    Yamasaki, S
    Mizumoto, M
    Mori, A
    Inoue, N
    Isobe, N
    Imamura, M
    INTERNATIONAL JOURNAL OF CANCER, 2000, 87 (05) : 665 - 672
  • [9] Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells
    Condiotti, R
    Nagler, A
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (07) : 571 - 579
  • [10] Synergistic antitumor effect of JAWSII dendritic cells and interleukin 12 in a melanoma mouse model
    Zapala, Lukasz
    Wolny, Rafal
    Wachowska, Malgorzata
    Jakobisiak, Marek
    Lasek, Witold
    ONCOLOGY REPORTS, 2013, 29 (03) : 1208 - 1214
1234